PIMG
MDCX

Patriot Investment Management Group’s Medicus Pharma MDCX Stock Holding History

Patriot Investment Management Group’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-29,203
Closed -$109K – 250
2025
Q1 		$109K Buy
29,203
+100
+0.3% +$314 0.01% 225
2024
Q4 		$70.7K Buy
+29,103
New +$73.9K 0.01% 234

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Patriot Investment Management Group's MDCX Position: Q2 2025 in Review

Patriot Investment Management Group sold out of Medicus Pharma (MDCX) in Q2 2025, closing a stake of 29,203 shares — an estimated $109K sold.

Patriot Investment Management Group first reported a position in MDCX in Q4 2024 and held it in 2 quarters. The position peaked at $109K in Q1 2025. 21 funds tracked by Wall St. Rank hold MDCX as of Q2 2025.

  • Patriot Investment Management Group reported no remaining Medicus Pharma position as of Q2 2025 after selling out during the quarter.
  • Patriot Investment Management Group sold 29,203 Medicus Pharma shares in Q2 2025, an estimated $109K.
  • Patriot Investment Management Group first reported a position in Medicus Pharma in Q4 2024 and held it in 2 quarters.
  • Patriot Investment Management Group's Medicus Pharma position peaked at $109K in Q1 2025.
  • 21 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2025.

Based on Patriot Investment Management Group's 13F filing for Q2 2025, filed 15 Jul 2025.